Lion Biotechnologies
Get verified emails for Lion Biotechnologies employees
About Lion Biotechnologies
|
|
|
1-10 employees
View all
|
|
Health Care
|
|
New York, New York
|
|
Lion Biotechnologies (LBIO) is focused on the development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes (TIL). Under a collaborative research and development agreement with Dr. Steven A. Rosenberg at the National Cancer Institute, we are investigating our our lead product candidate, LN-144, in the treatment of stage 4 metastatic melanoma. In clinical trials, LN-144 has demonstrated curative potential in patients with metastatic melanoma, and it may also be applicable to a wide range of other solid tumors.
|
Lion Biotechnologies Alternatives
Frequently Asked Questions about Lion Biotechnologies
Who are the decision makers in Lion Biotechnologies?
The decision makers in Lion Biotechnologies are Will Black, etc. Click to Find Lion Biotechnologies decision makers emails.
Lion Biotechnologies Staff Directory
Search Lion Biotechnologies Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Search Portal
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
